{"id":"https://openalex.org/W7202076146","doi":"https://doi.org/10.3390/endocrines7030044","title":"Psychiatric Adverse Events Associated with GLP-1 Receptor Agonists: Evidence of Intraclass Heterogeneity in the WHO VigiBase Global Database","display_name":"Psychiatric Adverse Events Associated with GLP-1 Receptor Agonists: Evidence of Intraclass Heterogeneity in the WHO VigiBase Global Database","publication_year":2026,"publication_date":"2026-08-10","ids":{"openalex":"https://openalex.org/W7202076146","doi":"https://doi.org/10.3390/endocrines7030044"},"language":"en","primary_location":{"id":"doi:10.3390/endocrines7030044","doi":"https://doi.org/10.3390/endocrines7030044","is_oa":true,"landing_page_url":"https://doi.org/10.3390/endocrines7030044","pdf_url":null,"source":{"id":"https://openalex.org/S4210215155","display_name":"Endocrines","issn_l":"2673-396X","issn":["2673-396X"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj"],"host_organization":"https://openalex.org/P4310310987","host_organization_name":"Multidisciplinary Digital Publishing Institute","host_organization_lineage":["https://openalex.org/P4310310987"],"host_organization_lineage_names":["Multidisciplinary Digital Publishing Institute"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Endocrines","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","doaj"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://doi.org/10.3390/endocrines7030044","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5037139141","display_name":"Esteban Zavaleta\u2010Monestel","orcid":"https://orcid.org/0000-0003-3726-0079","observed_orcids":["https://orcid.org/0000-0003-3726-0079"]},"institutions":[],"countries":[],"is_corresponding":true,"raw_author_name":"Esteban Zavaleta-Monestel","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5070446816","display_name":"Sebasti\u00e1n Arguedas\u2010Chac\u00f3n","orcid":"https://orcid.org/0000-0001-8547-7745","observed_orcids":["https://orcid.org/0000-0001-8547-7745"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Sebasti\u00e1n Arguedas-Chac\u00f3n","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0001-8547-7745","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5117230174","display_name":"Jeaustin Mora-Jim\u00e9nez","orcid":"https://orcid.org/0009-0001-0543-2262","observed_orcids":["https://orcid.org/0009-0001-0543-2262"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Jeaustin Mora-Jim\u00e9nez","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5015348609","display_name":"Jorge Arturo Villalobos-Madr\u00edz","orcid":"https://orcid.org/0009-0005-7404-0106","observed_orcids":["https://orcid.org/0009-0005-7404-0106"]},"institutions":[{"id":"https://openalex.org/I4210150661","display_name":"Latin University of Costa Rica","ror":"https://ror.org/04yd0ad61","country_code":"CR","type":"education","lineage":["https://openalex.org/I4210150661"]}],"countries":["CR"],"is_corresponding":false,"raw_author_name":"Jorge Arturo Villalobos-Madriz","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5138820518","display_name":"Brandon Enr\u00edquez-Guti\u00e9rrez","orcid":"https://orcid.org/0009-0001-1799-3710","observed_orcids":["https://orcid.org/0009-0001-1799-3710"]},"institutions":[{"id":"https://openalex.org/I4210150661","display_name":"Latin University of Costa Rica","ror":"https://ror.org/04yd0ad61","country_code":"CR","type":"education","lineage":["https://openalex.org/I4210150661"]}],"countries":["CR"],"is_corresponding":false,"raw_author_name":"Brandon Enr\u00edquez-Guti\u00e9rrez","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0009-0001-1799-3710","affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5138777626","display_name":"Kevin Tencio-Morales","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210150661","display_name":"Latin University of Costa Rica","ror":"https://ror.org/04yd0ad61","country_code":"CR","type":"education","lineage":["https://openalex.org/I4210150661"]}],"countries":["CR"],"is_corresponding":false,"raw_author_name":"Kevin Tencio-Morales","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5037139141"],"corresponding_institution_ids":[],"apc_list":{"value":1000,"currency":"CHF","value_usd":1207},"apc_paid":{"value":1000,"currency":"CHF","value_usd":1207},"fwci":0.0,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":{"value":0.0,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"7","issue":"3","first_page":"44","last_page":"44"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11943","display_name":"Pharmacovigilance and Adverse Drug Reactions","score":0.9937000274658203,"subfield":{"id":"https://openalex.org/subfields/3005","display_name":"Toxicology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T11943","display_name":"Pharmacovigilance and Adverse Drug Reactions","score":0.9937000274658203,"subfield":{"id":"https://openalex.org/subfields/3005","display_name":"Toxicology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10401","display_name":"Diabetes Treatment and Management","score":0.003599999938160181,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12539","display_name":"Pharmacology and Obesity Treatment","score":0.0003000000142492354,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/glp-1-receptor-agonists","display_name":"GLP-1 receptor agonists","score":0.9359999895095825},{"id":"https://openalex.org/keywords/semaglutide","display_name":"semaglutide","score":0.8880000114440918},{"id":"https://openalex.org/keywords/liraglutide","display_name":"liraglutide","score":0.9990000128746033},{"id":"https://openalex.org/keywords/tirzepatide","display_name":"tirzepatide","score":0.8619999885559082},{"id":"https://openalex.org/keywords/dulaglutide","display_name":"dulaglutide","score":0.9950000047683716},{"id":"https://openalex.org/keywords/exenatide","display_name":"exenatide","score":1.0},{"id":"https://openalex.org/keywords/pharmacovigilance","display_name":"pharmacovigilance","score":0.8080000281333923},{"id":"https://openalex.org/keywords/disproportionality-analysis","display_name":"disproportionality analysis","score":0.8560000061988831},{"id":"https://openalex.org/keywords/reporting-odds-ratio","display_name":"reporting odds ratio","score":0.718999981880188},{"id":"https://openalex.org/keywords/who-vigibase","display_name":"WHO VigiBase","score":0.75},{"id":"https://openalex.org/keywords/drug-safety-signals","display_name":"drug safety signals","score":0.5830000042915344},{"id":"https://openalex.org/keywords/anxiety","display_name":"anxiety","score":0.3790000081062317},{"id":"https://openalex.org/keywords/suicidal-ideation","display_name":"suicidal ideation","score":0.5559999942779541},{"id":"https://openalex.org/keywords/antipsychotic-side-effects","display_name":"antipsychotic adverse effects","score":0.4320000112056732}],"concepts":[{"id":"https://openalex.org/C57658597","wikidata":"https://www.wikidata.org/wiki/Q1550789","display_name":"Pharmacovigilance","level":3,"score":0.8920000195503235},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.822700023651123},{"id":"https://openalex.org/C199475168","wikidata":"https://www.wikidata.org/wiki/Q1539689","display_name":"MedDRA","level":4,"score":0.597599983215332},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.5645999908447266},{"id":"https://openalex.org/C118552586","wikidata":"https://www.wikidata.org/wiki/Q7867","display_name":"Psychiatry","level":1,"score":0.4984999895095825},{"id":"https://openalex.org/C156957248","wikidata":"https://www.wikidata.org/wiki/Q1862216","display_name":"Odds ratio","level":2,"score":0.49540001153945923},{"id":"https://openalex.org/C2780533449","wikidata":"https://www.wikidata.org/wiki/Q417762","display_name":"Exenatide","level":4,"score":0.44110000133514404},{"id":"https://openalex.org/C2778176773","wikidata":"https://www.wikidata.org/wiki/Q2976049","display_name":"Drug class","level":3,"score":0.41819998621940613},{"id":"https://openalex.org/C2777105317","wikidata":"https://www.wikidata.org/wiki/Q4686710","display_name":"Adverse Event Reporting System","level":3,"score":0.396699994802475},{"id":"https://openalex.org/C23276603","wikidata":"https://www.wikidata.org/wiki/Q158230","display_name":"Pharmacoepidemiology","level":3,"score":0.37610000371932983},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.37290000915527344},{"id":"https://openalex.org/C44249647","wikidata":"https://www.wikidata.org/wiki/Q208498","display_name":"Confidence interval","level":2,"score":0.37119999527931213},{"id":"https://openalex.org/C2779473830","wikidata":"https://www.wikidata.org/wiki/Q1540899","display_name":"MEDLINE","level":2,"score":0.3630000054836273},{"id":"https://openalex.org/C143095724","wikidata":"https://www.wikidata.org/wiki/Q515895","display_name":"Odds","level":3,"score":0.3605000078678131},{"id":"https://openalex.org/C2780035454","wikidata":"https://www.wikidata.org/wiki/Q8386","display_name":"Drug","level":2,"score":0.34369999170303345},{"id":"https://openalex.org/C2780051608","wikidata":"https://www.wikidata.org/wiki/Q42844","display_name":"Major depressive disorder","level":3,"score":0.3359000086784363},{"id":"https://openalex.org/C46578552","wikidata":"https://www.wikidata.org/wiki/Q2725393","display_name":"Global health","level":3,"score":0.3248000144958496},{"id":"https://openalex.org/C2781290027","wikidata":"https://www.wikidata.org/wiki/Q413879","display_name":"Golimumab","level":4,"score":0.2915000021457672},{"id":"https://openalex.org/C500440147","wikidata":"https://www.wikidata.org/wiki/Q701216","display_name":"Pharmacotherapy","level":2,"score":0.28189998865127563},{"id":"https://openalex.org/C95190672","wikidata":"https://www.wikidata.org/wiki/Q815382","display_name":"Meta-analysis","level":2,"score":0.2815999984741211},{"id":"https://openalex.org/C104863432","wikidata":"https://www.wikidata.org/wiki/Q614304","display_name":"Pharmacy","level":2,"score":0.2572000026702881},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.25200000405311584}],"mesh":[],"locations_count":3,"locations":[{"id":"doi:10.3390/endocrines7030044","doi":"https://doi.org/10.3390/endocrines7030044","is_oa":true,"landing_page_url":"https://doi.org/10.3390/endocrines7030044","pdf_url":null,"source":{"id":"https://openalex.org/S4210215155","display_name":"Endocrines","issn_l":"2673-396X","issn":["2673-396X"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj"],"host_organization":"https://openalex.org/P4310310987","host_organization_name":"Multidisciplinary Digital Publishing Institute","host_organization_lineage":["https://openalex.org/P4310310987"],"host_organization_lineage_names":["Multidisciplinary Digital Publishing Institute"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Endocrines","raw_type":"journal-article"},{"id":"doi:10.20944/preprints202606.2007.v1","doi":"https://doi.org/10.20944/preprints202606.2007.v1","is_oa":true,"landing_page_url":"https://doi.org/10.20944/preprints202606.2007.v1","pdf_url":null,"source":{"id":"https://openalex.org/S6309402219","display_name":"Preprints.org","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":["https://openalex.org/P4310310987"],"host_organization_lineage_names":["Multidisciplinary Digital Publishing Institute"],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"posted-content"},{"id":"pmh:oai:doaj.org/article:47420f0c4ba84f97a2d9899c691f2176","doi":null,"is_oa":false,"landing_page_url":"https://doaj.org/article/47420f0c4ba84f97a2d9899c691f2176","pdf_url":null,"source":{"id":"https://openalex.org/S4306401280","display_name":"DOAJ (DOAJ: Directory of Open Access Journals)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Endocrines, Vol 7, Iss 3, p 44 (2026)","raw_type":"article"}],"best_oa_location":{"id":"doi:10.3390/endocrines7030044","doi":"https://doi.org/10.3390/endocrines7030044","is_oa":true,"landing_page_url":"https://doi.org/10.3390/endocrines7030044","pdf_url":null,"source":{"id":"https://openalex.org/S4210215155","display_name":"Endocrines","issn_l":"2673-396X","issn":["2673-396X"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj"],"host_organization":"https://openalex.org/P4310310987","host_organization_name":"Multidisciplinary Digital Publishing Institute","host_organization_lineage":["https://openalex.org/P4310310987"],"host_organization_lineage_names":["Multidisciplinary Digital Publishing Institute"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Endocrines","raw_type":"journal-article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":1.0}],"study_designs":[{"id":"https://openalex.org/study-designs/observational-study","display_name":"Observational Study"}],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":30,"referenced_works":["https://openalex.org/W2000096914","https://openalex.org/W2804438070","https://openalex.org/W3022423927","https://openalex.org/W3087290101","https://openalex.org/W3121486073","https://openalex.org/W3139003019","https://openalex.org/W3173421961","https://openalex.org/W4224218205","https://openalex.org/W4285592761","https://openalex.org/W4379509131","https://openalex.org/W4388592674","https://openalex.org/W4389681767","https://openalex.org/W4391261634","https://openalex.org/W4391653666","https://openalex.org/W4396696102","https://openalex.org/W4400415068","https://openalex.org/W4401715897","https://openalex.org/W4402169113","https://openalex.org/W4406602151","https://openalex.org/W4408591747","https://openalex.org/W4408726407","https://openalex.org/W4409119298","https://openalex.org/W4410362965","https://openalex.org/W4410885131","https://openalex.org/W4411347509","https://openalex.org/W4411572669","https://openalex.org/W4415459168","https://openalex.org/W4416438985","https://openalex.org/W4417078467","https://openalex.org/W7128396185"],"related_works":["https://openalex.org/W4401063376","https://openalex.org/W4411347509","https://openalex.org/W4391653666","https://openalex.org/W4412736119","https://openalex.org/W7162416298","https://openalex.org/W7170057227","https://openalex.org/W4411572669","https://openalex.org/W7171523744","https://openalex.org/W4409147963","https://openalex.org/W4407113532"],"abstract_inverted_index":{"Background/Objectives:":[0],"Concerns":[1],"regarding":[2],"the":[3,17,41,60,72,77,119,128,142,157,186,245],"psychiatric":[4,65,172,189,235,276],"safety":[5,97,236],"profile":[6,237],"of":[7,64,150,188,203,238,275],"glucagon-like":[8],"peptide-1":[9],"receptor":[10],"agonists":[11],"(GLP-1":[12],"RAs)":[13],"have":[14],"increased":[15],"since":[16],"2023":[18],"European":[19],"Medicines":[20],"Agency":[21],"(EMA)":[22],"and":[23,26,54,111,144,198,216,226,270],"U.S.":[24],"Food":[25],"Drug":[27],"Administration":[28],"(FDA)":[29],"reviews.":[30],"However,":[31],"it":[32],"remains":[33],"unclear":[34],"whether":[35],"this":[36],"signal":[37,250],"is":[38,241,251],"uniform":[39],"across":[40,156],"drug":[42,67],"class":[43],"or":[44],"concentrated":[45,252],"in":[46,56,184,199,278],"specific":[47,283],"compounds.":[48],"This":[49,138],"study":[50,91,139],"aimed":[51],"to":[52,141,168,256,268],"characterize":[53],"compare,":[55],"a":[57,257],"systematic":[58],"manner,":[59],"global":[61,83],"reporting":[62,162,205],"patterns":[63],"adverse":[66],"reactions":[68],"(ADRs)":[69],"associated":[70],"with":[71,133,160,180,281],"main":[73],"GLP-1":[74,239],"RAs":[75,240],"using":[76,127],"World":[78],"Health":[79],"Organization":[80],"(WHO)":[81],"VigiBase":[82],"pharmacovigilance":[84,90],"database.":[85],"Methods:":[86],"A":[87,113,148],"descriptive,":[88],"cross-sectional":[89],"was":[92,116,165],"conducted":[93],"on":[94,253],"individual":[95],"case":[96],"reports":[98,153,190],"(ICSRs)":[99],"retrieved":[100],"from":[101],"VigiAccess":[102],"(January":[103],"2000\u20132026)":[104],"for":[105,177,192,196,209],"semaglutide,":[106],"liraglutide,":[107],"dulaglutide,":[108,225],"exenatide,":[109],"tirzepatide,":[110,224],"lixisenatide.":[112],"disproportionality":[114,200,249],"analysis":[115],"performed":[117],"within":[118,244],"MedDRA":[120],"\u201cPsychiatric":[121],"disorders\u201d":[122],"System":[123],"Organ":[124],"Class":[125],"(SOC)":[126],"Reporting":[129],"Odds":[130],"Ratio":[131],"(ROR)":[132],"95%":[134,213,220],"confidence":[135],"intervals":[136],"(CIs).":[137],"adhered":[140],"STROBE":[143],"READUS-PV":[145],"guidelines.":[146],"Results:":[147],"total":[149],"537,519":[151],"ADR":[152],"were":[154,206],"analyzed":[155],"five":[158],"drugs":[159],"sufficient":[161],"volume":[163],"(lixisenatide":[164],"excluded":[166],"owing":[167],"n":[169],"=":[170],"22":[171],"events).":[173],"Psychiatric":[174],"disorders":[175],"accounted":[176],"24,899":[178],"reports,":[179],"marked":[181],"intraclass":[182],"heterogeneity":[183],"both":[185],"proportion":[187],"(6.73%":[191],"semaglutide":[193,210,254],"versus":[194],"3.12%":[195],"tirzepatide)":[197],"estimates.":[201],"Signals":[202],"disproportionate":[204],"identified":[207],"exclusively":[208],"(ROR":[211,218],"1.55;":[212],"CI":[214,221],"1.50\u20131.59)":[215],"liraglutide":[217],"1.19;":[219],"1.15\u20131.23),":[222],"whereas":[223],"exenatide":[227],"showed":[228],"point":[229],"estimates":[230],"below":[231],"unity.":[232],"Conclusions:":[233],"The":[234,248],"not":[242],"homogeneous":[243],"therapeutic":[246],"class.":[247],"and,":[255],"lesser":[258],"extent,":[259],"liraglutide.":[260],"These":[261],"findings":[262],"extend":[263],"previous":[264],"WHO-based":[265],"analyses":[266],"limited":[267],"suicidality":[269],"support":[271],"active":[272],"clinical":[273],"surveillance":[274],"symptoms":[277],"patients":[279],"treated":[280],"these":[282],"agents.":[284]},"counts_by_year":[],"updated_date":"2026-11-12T12:28:57.059296","created_date":"2026-08-10T00:00:00"}